Global Antibiotic Research and Development Partnership (GARDP)

https://www.gardp.org

Launched in May 2016 by the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi), GARDP aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging, or for which inadequate treatment exists, while endeavouring to ensure sustainable access. In its 2017-2023 Business Plan, GARDP aims to develop up to four new treatments through the improvement of existing antibiotics and acceleration of the entry of new chemical entities. GARDP is incubated by DNDi, which currently provides GARDP’s governance. GARDP would like to acknowledge its seed donors, the German Federal Ministry of Health, UK Department for International Development, Médecins Sans Frontières, Swiss Federal Office of Public Health, Netherlands Ministry of Health, Welfare and Sport, and South African Medical Research Council, without whose support it could not have started. *

	Start	2016-05-01 established jv
	Group	UN (United Nations)
	Industry	antibiotic
	Industry 2	drug development

	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Global Antibiotic Research and Development Partnership (GARDP). (9/4/17). "Press Release: More than EUR 56 Million Raised to Fund Initiative to Fight Antibiotic Resistance". Berlin.

		Record changed: 2023-07-10